α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action.
Lancet Respir Med
; 9(4): 337-339, 2021 04.
Article
in English
| MEDLINE | ID: covidwho-1492859
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Alpha 1-Antitrypsin
/
Alpha 1-Antitrypsin Deficiency
/
COVID-19
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Limits:
Humans
Language:
English
Journal:
Lancet Respir Med
Year:
2021
Document Type:
Article
Affiliation country:
S2213-2600(21)00018-7
Similar
MEDLINE
...
LILACS
LIS